wagti.

[Eterna Labs @eterna_labs]

🧾 [Log #ΞL-047]
Live Transmission

Discussion now live:
– Deepening our partnership with Rapamycin Longevity Lab
– Collaboration with AgelessRx to expand access to clinically guided, personalized Rapamycin protocols

Join the conversation 👇

[Eterna Labs @eterna_labs]

🧾 [Log #ΞL-046]
Compound: $RAP (Rapamycin)
Subject: Partnership deepened with Rapamycin Longevity Labs (@OMIPALRLL)

Observation:
Eterna Labs and Rapamycin Longevity Labs (founded by @KristerKauppi, the “godfather” of Rapamycin) have been closely aligned in advancing longevity science.

– To formalize and deepen this partnership, we have sent :
• 1.5% of $RAP → Rapamycin Longevity Labs

Interpretation:
By securing aligned positions in $RAP, we create a unified foundation to accelerate Rapamycin research. This alignment strengthens credibility, simplifies collaboration with scientists, and ensures both labs are co-invested in the long-term vision.

Implication:
– Focus: Building the largest real-world human data set for Rapamycin ever recorded.
– Method: Financing scientists for structured self-experiments, enhancing accessibility to those interested in taking rapamycin for longevity, and onboarding the growing community of self-experimenters already taking Rapamycin,
– Support: Collaboration with AgelessRx to streamline access to Rapamycin with clinically guided and personalized longevity protocols
– Outcome: From individual data points to exponential knowledge growth, enabling a transparent, real-world evidence base for Rapamycin.

Status:
Rapamycin Longevity Labs is now officially part of the $RAP dev team and research network. Together, we aim to write the next chapter in Rapamycin’s history.

[Eterna Labs @eterna_labs]

Captain Longevity

[Eterna Labs @eterna_labs]

🧾 [Log #ΞL-040]
Compound: $PILL / $RAP
Subject: AUM efficiency — undervaluation exposed

Observation:
@icmdotrun : $24k AUM → $8.6M market cap.
@eterna_labs : $40k AUM → just $70k market cap.

Interpretation:
– Ratio check: Eterna Labs is ~200x more capital efficient than ICM.
– If $PILL were valued like ICM, its market cap wouldn’t be $70k… it would be $14.3M+.

Implication:
Eterna Labs is massively undervalued.
With $PILL and $RAP, every dollar in AUM directly fuels longevity research, not just optics.

Status:
The data speaks for itself. Eterna Labs isn’t just efficient, it’s the most undervalued longevity DAO in the space.

[Eterna Labs @eterna_labs]

[Log #ΞL-039]
Compound: $RAP (Rapamycin)
Subject: Toward the largest dosing dataset

Observation:
– Rapamycin is the most validated longevity compound, yet dosing guidance remains fragmented.
– Today, individuals navigate without a clear roadmap for optimal, personalized regimens.
– Data is scattered across forums, small trials, and anecdotes, limiting progress.

Interpretation:
Through $RAP and Eterna Labs, we aim to consolidate every datapoint, from worms, flies, mice, and humans, into the most comprehensive dosing dataset ever assembled.
This will allow each individual to eventually identify their own optimal dose for maximal lifespan and healthspan.

Implication:
Longevity science advances not only through discovery, but through structure.
By building this shared dataset, $RAP becomes more than a token: it is the foundation of personalized rapamycin use, accessible to all.

Status:
The unfinished work of science becomes the collective mission of Eterna Labs.

[Eterna Labs @eterna_labs]

🧾[Log #ΞL-038]
Series: Rapamycin Longevity Series – Field Notes

Episode: Ross Pelton (Natural Pharmacist and the author of 12 books in the health field) — Mechanism, Use, and Clinical Promise

Purpose: Establish a clear, accessible baseline on rapamycin’s biology, dosing logic, benefits, risks, and real-world adoption based on Ross Pelton’s interview. This initiates Eterna Labs’ multi-part analysis of the series.

[wagti. @wagticorp]

@eterna_labs @pumpdotscience Wondering if AI16Z and BADDIES are taking some $RAP to protect BOOBS.

[Eterna Labs @eterna_labs]

🧾 [Log #ΞL-036]
Subject: Longevity enters the global stage

Observation:
At Beijing’s WWII parade, a hot-mic caught President

Putin’s translator:

“Biotechnology is continuously developing… Human organs can be continuously transplanted. The longer you live, the younger you become… even achieve immortality.”

President Xi replied:

“Some predict that in this century humans may live to 150 years old.”

Interpretation:
Rapamycin, originally FDA-approved for organ transplants, is already central to this narrative. Beyond transplantation, it is the most validated compound for extending lifespan and healthspan across species.

Eterna lens:
Rapamycin is not only a transplant drug; it is the protagonist of longevity science.
With RAP on-chain, flies → mice → human experiments advance.
The rhetoric of world leaders meets the reality of decentralized science.

[Eterna Labs @eterna_labs]

[Log #ΞL-034]
Project: ETERNA – AI Integration
Subject: BADDIE Framework

Observation:
On August 28th, our partner @Big_Pharmai officially launched BADDIE, their AI-driven research framework: https://t.co/Qj8DMPCgtz.

Through our strategic partnership announced earlier this summer, Eterna Labs now operates at the highest tier of access — KINGPIN.

Implications:
– Direct leverage of AI-assisted compound discovery and protocol design
– Enhanced dosing insights and experimental optimization for $RAP and future compounds
– Unlimited research queries and deployment of Big PharmAI-funded launches

Purpose:
– Accelerate DeSci experiments through next-gen computational support
– Strengthen scientific validation of longevity compounds
– Amplify Eterna Labs’ position at the frontier of AI x longevity

Status:
BADDIE framework live.
Tier KINGPIN secured.

[Eterna Labs @eterna_labs]

[Log #ΞL-033]
Compound: $RAP (Rapamycin)
Subject: Response to critique

Observation:
Nootropics DAO recently suggested: “Rapamycin is overrated.”

Critique is often the first reaction of those uncomfortable with their own position. Without rapamycin, longevity science would likely not be where it stands today.

Contextual analogy:
– In childhood, we revere our parents.
– In adolescence, we reject them.
– With maturity, we recognize their indispensable role.

Rapamycin is no different: the “parent” of modern longevity research. Adoration, rejection, and eventual respect are all part of the cycle.

Note:
Let’s not be too harsh on the intern at Nootropics DAO, likely in the middle of their own adolescent crisis. Soon enough, they too will recognize the indispensable role of rapamycin in longevity research.

Status:
$RAP remains the gold standard. The foundation upon which the field continues to build.

[Eterna Labs @eterna_labs]

[Log #ΞL-032]
Compound: $RAP (Rapamycin)
Subject: Scientific validation – DNA damage resilience

Observation:
A new peer-reviewed preprint (bioRxiv, Aug 2025) provides strong evidence that low-dose rapamycin directly protects the ageing human immune system against DNA damage.

Key Findings:
– Rapamycin reduced DNA lesion burden in human T cells under genotoxic stress (zeocin, H₂O₂).
– This effect was independent of protein synthesis inhibition, autophagy, or cell cycle arrest.
– In a 4-month clinical trial (NCT05414292), older adults on low-dose rapamycin showed:
 • Reduced DNA-damage induced senescence markers (p21, p53, γH2AX).
 • Lower immune exhaustion signals (KLRG1, LAG3, NKG2A).
 • No signs of immunosuppression.

Implications:
– Rapamycin emerges as a genoprotective agent: stabilizing genome integrity in immune cells.
– Positions $RAP as a leading candidate for healthy ageing, cancer adjuvant therapy, radiation protection, and extreme environments (e.g., space travel).

Status:
Data strengthens rapamycin’s profile as the gold standard of longevity science, with direct translational relevance for human health.

Full paper: https://t.co/wpl8Q0EP25

[Eterna Labs @eterna_labs]

[Log #ΞL-031]
Project: Eterna Labs – AUM Update
Compound: $AGELESS

Status:
Eterna Labs protocol reserves have received 10,000,000 $AGELESS tokens (1% of supply), generously contributed by @BowTiedShrike — developer of @ageless_coin.

Compound Profile:
– Curcumin: anti-inflammatory, telomere lengthening, autophagy activation
– Tadalafil: PDE5 inhibitor, cardiovascular protection, vascular support
– Hydroxypropyl-β-cyclodextrin (HPCD): sterol turnover, drug delivery enhancer, emerging promise in Alzheimer’s research

Purpose:
– Strengthen AUM with diversified longevity compounds
– Support early-stage research on promising multi-agent interventions
– Ensure long-term alignment between @ageless_coin and Eterna Labs

Status:
Assets integrated into protocol reserves.
Securely held for strategic alignment and experimental funding.

[Eterna Labs @eterna_labs]

[Log #ΞL-030]
Compound: $RAP (Rapamycin)
Subject: RAP/BIO Liquidity Pool Update

Observation:
The RAP/BIO pool (Raydium CLMM: H58TC6cVVnBQ3TL6Q7YrQ6bQnumYBfraybcsad54tBTh) has been updated.

Metrics:
– TVL: $17,759
– Farming Rewards: 5M $RAP distributed over 30 days
– Current APR: 149%
 • 114.45% from $RAP rewards
 • 34.57% from trade fees

Purpose:
– Incentivize deeper liquidity
– Provide yield opportunities for $RAP and $BIO holders
– Strengthen trading infrastructure for validated longevity assets

Status:
Liquidity farming active.
APR up to 149%.

[Eterna Labs @eterna_labs]

[Log #ΞL-029]
Project: Eterna Labs
Subject: AUM Update

Status:
Net Asset Value (NAV): $81,581.18

Initial value at DAO launch:
20 SOL (~$3,400)

Observation:
From a modest launch with 20 SOL, Eterna Labs’ AUM has scaled into a diversified portfolio of leading DeSci compounds, securing both long-term exposure and strategic influence across the ecosystem.

Purpose:
– Reinforce protocol reserves
– Secure long-term exposure to high-potential compounds
– Support $RAP and $PILL buyback capacity

Data monitoring continues.

[wagti. @wagticorp]

@0xBrrrr @KingAlexander50 @pumpdotscience @SMER28RAPA lmao

[Octopus Lab ™ @Octopuslaboff]

Pas mal de Hype autour de la #DESCI en ce moment ⚗️🧪

Notre main runner prediction est $RAP by @eterna_labs, l'une des meilleures team actuelle !

Il est actuellement à 300k de marketcap ($0.00031), une fois qu'il breakera son ATH à 600k, rien ne pourra l'arrêter. Nous en avons pris à 170k et nous en avons repris à ces niveaux.

Ils ont récemment eu une pool en partenariat avec
@BioProtocol, signe d'intérêt croissant pour ce projet.

C'est le gold standard de la longévité !

#RAPAMYCIN

[wagti. @wagticorp]

@txdotlol lol wtf?

[Eterna Labs @eterna_labs]

[Log #ΞL-025]
Compound: $RAP (Rapamycin)
Subject: BIOPSY Liquidity Proposal — Voting Live

Observation:
The joint liquidity provision proposal between @pumpdotscience, @BioProtocol, and @eterna_labs is now live for voting on Snapshot.

🗳️ Link: https://t.co/l8hVO1ktpE

Current results:
✅ For: 9.5m (99.95%)
➖ Abstain: 4.8k (0.05%)
❌ Against: 0 (0%)

Purpose:
– Deepen liquidity pools for scientifically validated compounds (starting with $RAP).
– Provide $BIO holders exposure to top-performing assets.
– Create token sinks + recurring fee revenue across protocols.

Call to Action:
The vote is live until Aug 24.
We invite all $BIO holders to cast their vote and support this step toward scaling DeSci liquidity and cross-protocol growth.

[Eterna Labs @eterna_labs]

[Log #ΞL-019]
Compound: RAP (Rapamycin)
Subject: Scientific validation

Observation:
In the Rapamycin Longevity Series, Dr. @MannickJoan, one of the world’s leading researchers on mTOR inhibition, stated:

“There is no better validated single drug than rapamycin, for extending health span and lifespan.”

Interpretation:
– RAP is not just another candidate compound, it is the benchmark for longevity research.
– The strongest experimental validation to date positions RAP as the reference point against which all future interventions are measured.

Status:
Protocol alignment continues.
RAP remains the gold standard of longevity science.

https://t.co/vI2wwPik5D

[wagti. @wagticorp]

@pumpdotscience Lfg